Job was saved successfully.
Job was removed from Saved Jobs.

Job Details

GlaxoSmithKline (GSK)

Director, Companion Diagnostics (Oncology)




Waltham, Massachusetts, United States

Site Name: USA - Massachusetts - Waltham
Posted Date: Sep 21 2022

As a Diagnostics (Dx) team member you will lead efforts to implement GSK diagnostic strategy including technical, clinical, regulatory, commercial, intellectual property and business development components by leading diagnostic projects and work streams according to agreed deliverables, timelines and budget. The aforementioned functional areas will partner with you to develop and commercialize Dx across therapeutic areas, with a main focus in Specialty programs such as liver diseases, Celiac’s disease, and neurodegenerative diseases and may include some oncology companion diagnostic programs.

Dx team members execute precision medicine approaches in drug development through building collaboration within the GSK cross functional biomarker network and with external, diagnostic partners.


  • Lead the end-to-end diagnostics strategy and diagnostics matrix team within early and late stage therapeutic programs to align all diagnostic development milestones with clinical development milestones and overall biomarker strategy. May also actively contribute to the overall program strategy and may be a member of Early Development Teams or Medicine Development Teams.
  • Manage a team of 1-2 associates and support their programs and development.
  • Accountable for all aspects of diagnostic development with external partners to develop, validate, implement, register and launch diagnostic tests required for therapeutic program regulatory approval.
    • Establish and manage strategic partnerships to deliver diagnostic solutions to support the therapeutic program and the broader therapeutic pipeline.
    • Oversee all technical aspects of development, assay validation and clinical implementation of the diagnostic assays across a program.
    • Collaborate with clinical operations and sample management to ensure diagnostic testing and data generation is compliant with all regulatory requirements.
    • Exhibit timely management and delivery of projects/work streams within agreed budget.
    • Leads matrix to ensure efficient implementation of all key deliverables for the diagnostic project.
  • Lead the writing and/or the review of diagnostic portions of briefing documents, informed consents, clinical protocols, schedule of activities, clinical study reports, IDE, EU-IVDR, PMDA, NMPA, US-510(k)/PMA, and/or other regulatory submissions. Directly interact with regulatory authorities when required.
  • Proactively identifies business issues/risks; proposes, recommends and implements strategies to manage implications and risks on business group level and/or clinical program timelines, budgets and goals. Actively makes decisions which balance risk/benefit with clear understanding of impact on project; takes action to mitigate risk where appropriate.
  • Builds and maintains networks with asset teams, regulatory, clinical and biomarker leads, TA heads, project management, finance, business operations and IVD partner joint project team members to ensure timely dissemination of information to appropriate levels to improve transparency.
  • Provides frequent project status updates related to diagnostic program deliverables to senior management and to senior level matrix teams, both internally and externally.
  • Where applicable, accountable for proposing, promoting and implementing key organizational process improvement initiatives in daily activities; may lead or drive such initiatives. Ensure learnings and best practices are shared across R&D.
  • Participate in the evaluation of advanced technologies for IVD and clinical biomarker development.
  • Coach and mentor direct reports and matrix team members and provide timely feedback and guidance to help them reach their goals.

Why You?

Required Qualifications:

  • Advanced degree in Biological Sciences; either Ph.D or M.S., or a Bachelor’s degree with appropriate pharmaceutical and IVD manufacturer experience.
  • Understanding of Specialty area drug discovery & development especially late stage development and regulatory approval process and life cycle management.
  • Experience with clinical trial design and execution (efficacy endpoints, biomarker testing), sample operations, data management and human biological specimen management)
  • Experience with IVD development including design history file evaluation, risk assessments and all related analytical and clinical validation requirements.
  • Proven track record of having supported diagnostic product development (e.g. pre-submission packets, SRD and IDE authoring and HDE/510k/PMA documentation) for class II and/or class III devices.
  • Broad knowledge of technical platforms that include IHC, immunoassay, PCR, NGS and novel assay technologies (digital pathology, liquid biopsy, multiplex technologies).
  • Experience performing due diligence and auditing vendors for CDx test placement.
  • Understanding of GCP/GCLP, CLIA, CAP, ISO15189 laboratory requirements.
  • Understanding of QSR regulations, GMP manufacturing, ISO13485, and FDA, EU and other ex-US medical device regulations.
  • Detail oriented with strong organization skills.
  • Exceptional written and verbal communication skills.
  • Outstanding track record leading teams in a matrix environment.
  • Able to manage multiple projects and work streams across TAs and R&D, including assessment of workload and resourcing requirements to deliver the team’s objectives
  • Able to represent GSK effectively in relationship building and due diligence and negotiations with external organizations, including academic institutions, vendors and CROs.
  • Experience managing others.

Preferred Qualifications:

  • Statistical analysis plan development and diagnostic analysis required to support regulatory submissions
  • Experience in supporting BIMO audits
  • Experience in more than one therapeutic area. Understanding of oncology area drug discovery & development especially late stage development and regulatory approval process and life cycle management
  • Experience in supporting Dx developments in ex-US countries.

Why GSK?

We’re uniting science, technology and talent to make a difference in more people’s lives, and revolutionising the way we do R&D.

We’re combining the power of genetic and genomic insights into what causes disease, with the speed and scale of artificial intelligence and machine learning (AI/ML) to make better predictions about who a treatment might work for, and why. We believe this powerful combination of data and technology holds the key to fundamentally transforming medical discovery for the better, improving R&D success rates and shaping how even the most challenging diseases, like neurological conditions and cancer, can be both prevented and treated.

Our pipeline currently comprises of more than 60 vaccines and medicines across four core therapeutic areas including infectious diseases, HIV, oncology and immunology as well at pursuing other science-led opportunities outside our core areas. Many have the potential to be first or best-in-class opportunities for patients and since 2017, we’ve delivered 13 major approvals and more than doubled the number of potential new vaccines and medicines in Phase 3 and registration to 23.

In 2021 we delivered four major product approvals: Cabenuva for HIV, Jemperli for endometrial cancer, Xevudy for COVID-19 and Apretude, our new long-acting medicine for HIV prevention.

Find out more:

[Register to View] .

GSK is a global biopharma company with a special purpose – to unite science, technology and talent to get ahead of disease together – so we can positively impact the health of billions of people and deliver stronger, more sustainable shareholder returns – as an organisation where people can thrive. Getting ahead means preventing disease as well as treating it, and we aim to impact the health of 2.5 billion people around the world in the next 10 years.

Our success absolutely depends on our people. While getting ahead of disease together is about our ambition for patients and shareholders, it’s also about making GSK a place where people can thrive. We want GSK to be a workplace where everyone can feel a sense of belonging and thrive as set out in our Equal and Inclusive Treatment of Employees policy. We’re committed to being more proactive at all levels so that our workforce reflects the communities we work and hire in, and our GSK leadership reflects our GSK workforce.

If you require an accommodation or other assistance to apply for a job at GSK, please contact the GSK Service Centre at 1-[Register to View] (US Toll Free) or +1 [Register to View] (outside US).

GSK is an Equal Opportunity Employer and, in the US, we adhere to Affirmative Action principles. This ensures that all qualified applicants will receive equal consideration for employment without regard to race, color, national origin, religion, sex, pregnancy, marital status, sexual orientation, gender identity/expression, age, disability, genetic information, military service, covered/protected veteran status or any other federal, state or local protected class.

At GSK, the health and safety of our employees are of paramount importance. As a science-led healthcare company on a mission to get ahead of disease together, we believe that supporting vaccination against COVID-19 is the single best thing we can do in the US to ensure the health and safety of our employees, complementary workers, workplaces, customers, consumers, communities, and the patients we serve.

GSK has made the decision to require all US employees to be fully vaccinated against COVID-19, where allowed by state or local law and where vaccine supply is readily available. The only exceptions to this requirement are employees who are approved for an accommodation for religious, medical or disability-related reasons.

Important notice to Employment businesses/ Agencies

GSK does not accept referrals from employment businesses and/or employment agencies in respect of the vacancies posted on this site. All employment businesses/agencies are required to contact GSK's commercial and general procurement/human resources department to obtain prior written authorization before referring any candidates to GSK. The obtaining of prior written authorization is a condition precedent to any agreement (verbal or written) between the employment business/ agency and GSK. In the absence of such written authorization being obtained any actions undertaken by the employment business/agency shall be deemed to have been performed without the consent or contractual agreement of GSK. GSK shall therefore not be liable for any fees arising from such actions or any fees arising from any referrals by employment businesses/agencies in respect of the vacancies posted on this site.

Please note that if you are a US Licensed Healthcare Professional or Healthcare Professional as defined by the laws of the state issuing your license, GSK may be required to capture and report expenses GSK incurs, on your behalf, in the event you are afforded an interview for employment. This capture of applicable transfers of value is necessary to ensure GSK’s compliance to all federal and state US Transparency requirements. For more information, please visit GSK’s Transparency Reporting [Register to View] site.